Epilepsy, a misunderstood neurological disorder, affects millions worldwide, but with proper treatment, individuals can lead ...

Tommy Wyllie, 12, hopes first-of-its-kind study will transform the lives of young people with epilepsy.

Biohaven in recent months has reported a clinical stumble in spinal muscular atrophy, alongside a Phase I readout for its ...

Biohaven’s bipolar disorder candidate has failed to improve mania symptoms in a phase 2/3 trial. | Biohaven’s bipolar ...

AI model MELD Graph improves epilepsy lesion detection, outperforming current methods—enhancing diagnosis and treatment ...

Cassava's strong liquidity with $128.6 million in cash supports early-stage development, yet long-term funding needs may lead ...

Praxis' epilepsy pipeline takes center stage after Ulixacaltamide's Phase 3 futility. Key trials for vormatrigine and ...

Artificial intelligence (AI) could help detect abnormalities in the brain linked to epilepsy and lead to an earlier diagnosis ...

The Epi-Scot study, led by the University of Glasgow and NHS Greater Glasgow & Clyde, will investigate childhood epilepsy in ...

Using the technology in this way could lead to earlier diagnosis and better management of the condition, researchers suggest ...